RVNC: Prakiraan wutah bathi resik saben saham kanggo taun ngarep revance.com

Lambang korporat lan logo Revance Therapeutics (RVNC)

Revance Therapeutics (RVNC) is implementing energy-saving systems in its laboratories to minimize its environmental footprint. The earnings per share (EPS) forecast for the coming year confirms this strategic direction, with the 0.00 level serving as a critical benchmark. Growth is driven by the expansion of Daxxify into aesthetics and dystonia treatment, while the rapid increase in commercial sales of the drug creates powerful momentum for the company's current financial performance.

RVNC: Prakiraan wutah bathi resik saben saham ing taun ngarep Revance Therapeutics Inc 04.07.2022 - 16.02.2025

Rincian analitis lan laporan data perusahaan Revance Therapeutics Inc. (RVNC)

Analisis umum perusahaan:revance.com, RVNC
Produk dadi Revance Therapeutics, Inc.

This indicator aggregates analyst consensus forecasts for changes in net earnings per share, reflecting operational efficiency growth rates and future profitability. The stabilization of expected EPS growth for Revance Therapeutics (RVNC) next year confirms market confidence in the commercialization of Daxxify and the success of new clinical trials, minimizing investment risk uncertainty amid a productive innovation cycle.

Analisis perusahaan pesaing

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Krystal Biotech|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep APGE (Apogee Therapeutics)|Prakiraan wutah bathi kanggo taun ngarep ARQT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep VCEL (Vericel)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Oruka Corp ORKA|Prakiraan wutah bathi kanggo taun ngarep Sanara MedTech Inc. SMTI|DBVT: Prakiraan wutah bathi saben saham kanggo taun ngarep|SLSN: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Journey Medical Corp. (DERM) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|FBRX: Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep empro.my|SLGL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep AXIL|Prakiraan wutah bathi kanggo taun ngarep medicuspharma.com (MDCX)|Prakiraan wutah bathi kanggo taun ngarep VRCA (Verrica Pharmaceuticals Inc)|Dinamika bathi saben saham sing diarepake ing taun ngarep HOTH|BFRI: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep VYNE Therapeutics Inc.|SNOA: Prakiraan wutah bathi kanggo taun ngarep|Quoin Pharma (QNRX) - Prakiraan wutah bathi kanggo taun ngarep|AZTR (Azitra Inc) - Prakiraan wutah bathi kanggo taun ngarep|DRMA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Elevai Corp (ELAB)